What is the PAIN-Net project?

The PAIN-Net project is an Innovative Training Network (ITN) funded by the European Commission with the aim to train a new generation of creative, entrepreneurial and innovative early-stage researchers (ESR), able to face current and future challenges in neuropathic pain and to convert knowledge and ideas into products and services for economic and social benefit.

In line with this, PAIN-Net proposes an integrated programme that will provide ESRs with:

1) holistic approach to neuropathic and cancer pain pathophysiology, diagnosis, management and treatment through multidisciplinary training;

2) focused skills through direct involvement in innovative research programs at centres of excellence;

3) multi-sectoral environment, including clinical and research centres, as well as advanced centres for innovative animal model creation, high-throughput screening and biotechnology development;

4) exposure to the right combination of complementary skills, including career development and entrepreneurship able to enhance career perspectives in both the academic and non-academic sectors.

Relevance of neuropathic pain

Neuropathic pain affects 5% of the general population and 40% of patients with neurological diseases, and has a key role in the pathophysiology of cancer pain that affects up to 50% of patients in the early disease stage and 30% of survivors, overall causing an enormous burden in terms of patients’ quality of life and health care costs.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 721841